Drug Registration in ASEAN Countries
Drug Registration in ASEAN Countries
Drug Registration in ASEAN Countries
Brunei Cambodia
Malaysia Myanmar
Philippines Singapore
Thailand Vietnam
2004 8.23
2005 10.58
2006 21.58
2007 25.18
2008 38.13
Guar gum
Menthol
Chyawanprash
Clinical Pharmacology, Clinical efficacy, Safety etc. as required for CTD and
any other supporting documents like Clinical trial, comparative studies.
National policy on TM/CAM was issued in 1996 and regulations were issued in
1998. Regulation of herbal medicines in Cambodia was introduced in 1998. Herbal
medicines are regulated as over-the-counter medicines and for self-medication
only.
National policy on TM/CAM was included in the National Drug Policy issued
licensed practitioners. Lao PDR has its own has drug registration format and
Registration formats
Indonesia:
Traditional Medicines Name
Package size
Registration Number, name and industry address (at least
name of city and country)
Composition (species name of raw ingredient)
Effects/Usefulness
Usage
Warning and contra- indication (if exist)
Production Code Number
Expired Date
level of production/ Standard Operational Procedure; Utility or
machine Source of available raw ingredients
Quality Evaluation of Raw Ingredients
Methods and Test Result of Stability/Durability
Philippines:
APPLICATION FOR REGISTRATION OF PHARMACEUTICAL PRODUCT
To be filled up by the applicant
A.COMPANY APPLICANT
Company Name:
Complete Address:
Contact Numbers:
Type of establishment
Complete Name:
Complete Address:
B.TYPE OF APPLICATION
INITIAL REGISTRATION
RENEWAL REGISTRATION
MONITORED RELEASE EXTENSION
C.COMPLETE INFORMATION REGARDING THE PRODUCT
1. Generic Name (s):
2. Brand Name, if any:
3. Dosage Strength:
4. Dosage Form:
5. Route of Administration:
6. Pharmacologic Category:
7. Classification: Rx (Prescription Drug)
OTC (Over-the-Counter
Restricted/Regulated
Essential Drug List (EDL)
8. Claimed Shelf Life
9. Storage Condition
10. Primary Packaging (Market/Commercial Presentation):
11. Suggested Retail Price:
12. Reference Monograph:
Official:
Non-Official
Type of Product
Type of Dossier
Reference Product
Product
* intended for export
Product
*
Information
Forensic Classification
Vietnam:
3 Strength + + +
4 Color + + +
5 Commercial Presentations + + +
6 Country of Origin + +
7 Name of Applicant + + +
8 Business Address + + +
Phone
Fax
e-mail:
9 Name of Manufacturer + + +
Premises Address + + +
Postal Address
Phone
Fax
e-mail
11 Business Address +
Phone
Fax
e-mail
12 Product details + + +
18 Certificate of analysis + + +
20 Indication + + +
22 Contraindications + + +
24 Precautions + + +
28 Storage conditions + + +
30 Declaration by applicant +
01 Definition √ √ √ √ √ √ √ √ √ √ √ √
02 Nomenclature √ √ √ √ √ √ √ √ √
a. Botanical √ √ √ √ √ √ √ √ √
Nomenclature
b. Botanical Family √ √ √ √ √ √ √ √ √
03 Synonyms √ √ √ √ √ √ √ √ √ √
04 Selected vernacular √ √ √ √ √ √ √
names/ Common
Name
05 Description √ √ √ √ √ √ √ √
06 History √ √ √
07 Plant Material of √ √
interest
i. General Appearance √ √ √ √
Botanical √ √ √
Identification
ii Organoleptic √ √ √ √
properties
Macroscopic √ √ √ √ √ √ √ √ √
Identification
iii Microscopic √ √ √ √ √ √ √ √ √ √ √
characteristics
iv Powdered plant √ √ √ √ √ √
material
S. No. Headings WHO AHP ESCOP PDR EMEA BH BHP SLM IP API UP HP IHP ICM
community C R
monograph &
Quality tests
i Collection √ √
ii Cultivation √ √
iii Drying √
iv Handling √ √
v Storage √ √ √
vi Adulterants √ √
vii Preparations √ √
09 Geographical √ √ √ √ √ √
distribution
11 Purity tests √ √ √ √
i. Microbiology √ √ √ √
v. Alcohol-soluble √ √ √ √ √ √
extractive
ix Heavy Metals √ √ √ √
x Radioactive residues √ √
12 Chemical assays √ √ √ √ √ √ √ √
13 Major Chemical √ √ √ √ √ √ √ √ √ √
constituents/
Constituents
14 Dosage forms √ √ √ √ √ √ √ √ √ √ √
15 Adulterants and √ √
Substitutes
16 Therapeutics √ √ √ √ √ √ √ √
a. Pharmacokinetics √ √ √
b. Pharmacodynamics √ √ √
c. Preclinical Safety √
Data
17 Medicinal uses √ √ √ √ √ √
i. Uses supported by √ √ √ √
clinical data
18 Pharmacology √ √ √ √ √ √ √ √
a. Experimental √ √
pharmacology
b. Clinical √ √ √ √
pharmacology
19 Contraindications √ √ √ √ √
20 Warnings √ √
21 Pregnancy and √ √ √
lactation
22 Effects on ability to √ √
drive and use
machines
23 Overdose √ √ √
24. Precautions √ √ √ √ √ √ √
a. Carcinogenesis, √ √
mutagenesis,
impairment of
fertility
b. Other precautions √
c. Adverse reactions √ √ √ √ √
d. Interactions √ √
e. Posology √ √
f. Toxicology √ √
25 Regulatory Status √ √
26 References √ √ √ √ √ √